# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.41) per share. This is a 84.17 percent increase over losses ...
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.95) per share. This is a 75.13 percent increase over losses ...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.